Bone Mesenchymal Stem Cells with Growth Factors Successfully Treat Nonunions and Delayed Unions

Abstract

This study shows that percutaneous BMAC injection combined with either DBM and/or rhBMP-2 is a safe and effective treatment for delayed or nonunion regardless of the fracture gap size or fracture site. DBM may be superior to rhBMP-2 in this procedure.